123 related articles for article (PubMed ID: 120420)
1. Radiolabeled liposomes as metabolic and scanning tracers in mice. II. In-111 oxine compared with Tc-99m DTPA, entrapped in multilamellar lipid vesicles.
Espinola LG; Beaucaire J; Gottschalk A; Caride VJ
J Nucl Med; 1979 May; 20(5):434-40. PubMed ID: 120420
[TBL] [Abstract][Full Text] [Related]
2. The kinetics of 99m Tc-, 113m In-, and 169 Yb-DTPA compounds in brain sarcoma and kidneys of mice.
Haynie TP; Konikowski T; Glenn HJ
J Nucl Med; 1972 Mar; 13(3):205-10. PubMed ID: 5058238
[No Abstract] [Full Text] [Related]
3. Labeling of preformed liposomes with Ga-67 and Tc-99m by chelation.
Hnatowich DJ; Friedman B; Clancy B; Novak M
J Nucl Med; 1981 Sep; 22(9):810-4. PubMed ID: 7277025
[TBL] [Abstract][Full Text] [Related]
4. Biological distribution and excretion of DTPA labeled with Tc-99m and In-111.
McAfee JG; Gagne G; Atkins HL; Kirchner PT; Reba RC; Blaufox MD; Smith EM
J Nucl Med; 1979 Dec; 20(12):1273-8. PubMed ID: 536795
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of liposome-entrapped radioactive tracers as scanning agents. Part 1: Organ distribution of liposome (99mTc-DTPA) in mice.
Caride VJ; Taylor W; Cramer JA; Gottschalk A
J Nucl Med; 1976 Dec; 17(12):1067-72. PubMed ID: 993839
[TBL] [Abstract][Full Text] [Related]
6. Labeling of platelets with oxine complexes of Tc-99m and In-111. Part 1. In vitro studies and survival in the rabbit.
Wistow BW; Grossman ZD; McAfee JG; Subramanian G; Henderson RW; Roskopf ML
J Nucl Med; 1978 May; 19(5):483-7. PubMed ID: 417153
[TBL] [Abstract][Full Text] [Related]
7. Radiolabeling of lipid-based nanoparticles for diagnostics and therapeutic applications: a comparison using different radiometals.
Helbok A; Decristoforo C; Dobrozemsky G; Rangger C; Diederen E; Stark B; Prassl R; von Guggenberg E
J Liposome Res; 2010 Sep; 20(3):219-27. PubMed ID: 19863193
[TBL] [Abstract][Full Text] [Related]
8. Pretargeting with labeled bivalent peptides allowing the use of four radionuclides: (111)In, (131)I, (99m)Tc, and (188)Re.
van Schaijk FG; Oosterwijk E; Soede AC; Oyen WJ; McBride WJ; Griffiths GL; Goldenberg DM; Corstens FH; Boerman OC
Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3880S-5S. PubMed ID: 14506186
[TBL] [Abstract][Full Text] [Related]
9. Techniques for loading technetium-99m and rhenium-186/188 radionuclides into pre-formed liposomes for diagnostic imaging and radionuclide therapy.
Goins B; Bao A; Phillips WT
Methods Mol Biol; 2010; 606():469-91. PubMed ID: 20013416
[TBL] [Abstract][Full Text] [Related]
10. Retention of cytosine arabinoside in mouse lung following intravenous administration in liposomes of different size.
Hunt CA; Rustum YM; Mayhew E; Papahadjopoulos D
Drug Metab Dispos; 1979; 7(3):124-8. PubMed ID: 38080
[TBL] [Abstract][Full Text] [Related]
11. Liposome/white-cell interactions in vivo.
Palmer TN; Warner JP
Biosci Rep; 1983 May; 3(5):479-85. PubMed ID: 6349709
[TBL] [Abstract][Full Text] [Related]
12. Investigations of a new, highly negative liposome with improved biodistribution for imaging.
Hnatowich DJ; Clancy B
J Nucl Med; 1980 Jul; 21(7):662-9. PubMed ID: 7391841
[TBL] [Abstract][Full Text] [Related]
13. Doubly radiolabeled liposomes for pretargeted radioimmunotherapy.
Mougin-Degraef M; Bourdeau C; Jestin E; Saï-Maurel C; Bourgeois M; Saëc PR; Thédrez P; Gestin JF; Barbet J; Faivre-Chauvet A
Int J Pharm; 2007 Nov; 344(1-2):110-7. PubMed ID: 17592745
[TBL] [Abstract][Full Text] [Related]
14. Possible tumor localization of Tc-99m-labeled liposomes: effects of lipid composition, charge, and liposome size.
Richardson VJ; Jeyasingh K; Jewkes RF; Ryman BE; Tattersall MH
J Nucl Med; 1978 Sep; 19(9):1049-54. PubMed ID: 690706
[TBL] [Abstract][Full Text] [Related]
15. Design of liposomes to improve delivery of macrophage-augmenting agents to alveolar macrophages.
Fidler IJ; Raz A; Fogler WE; Kirsh R; Bugelski P; Poste G
Cancer Res; 1980 Dec; 40(12):4460-6. PubMed ID: 7002293
[TBL] [Abstract][Full Text] [Related]
16. Necrosis avidity of (99m)Tc(CO)3-labeled pamoic acid derivatives: synthesis and preliminary biological evaluation in animal models of necrosis.
Fonge H; Chitneni SK; Lixin J; Vunckx K; Prinsen K; Nuyts J; Mortelmans L; Bormans G; Ni Y; Verbruggen A
Bioconjug Chem; 2007; 18(6):1924-34. PubMed ID: 17929883
[TBL] [Abstract][Full Text] [Related]
17. Liposome kinetics in infarcted canine myocardium.
Caride VJ; Twickler J; Zaret BL
J Cardiovasc Pharmacol; 1984; 6(6):996-1005. PubMed ID: 6084791
[TBL] [Abstract][Full Text] [Related]
18. Effects of liposome structure and lipid composition on the activation of the tumoricidal properties of macrophages by liposomes containing muramyl dipeptide.
Schroit AJ; Fidler IJ
Cancer Res; 1982 Jan; 42(1):161-7. PubMed ID: 7053846
[TBL] [Abstract][Full Text] [Related]
19. Effect of liposome size on peritoneal retention and organ distribution after intraperitoneal injection in mice.
Mirahmadi N; Babaei MH; Vali AM; Dadashzadeh S
Int J Pharm; 2010 Jan; 383(1-2):7-13. PubMed ID: 19729056
[TBL] [Abstract][Full Text] [Related]
20. Preparation, characterisation and biodistribution of 99mTc-labeled liposome encapsulated cyclosporine.
Arulsudar N; Subramanian N; Mishra P; Sharma RK; Murthy RS
J Drug Target; 2003 Apr; 11(3):187-96. PubMed ID: 13129826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
